Design, synthesis and biological activity of acyl substituted 3-amino-5-methyl-1,4,5,7-tetrahydropyrazolo[3,4-b]pyridin-6-ones as potential hypnotic drugs

Eur J Med Chem. 2005 Nov;40(11):1179-87. doi: 10.1016/j.ejmech.2005.06.008. Epub 2005 Aug 10.

Abstract

Among the known non-benzodiazepinic hypnotic drugs acting on the alpha1 subunit of the GABA-A receptor, Zolpidem, Zaleplon and Indiplon have showed high affinity and selectivity. Following a design methodology including pharmacophoric requirements and ADME-predicted properties, we have synthesized a library of 3-amino-4,5-dihydro-1H-pyrazolo[3,4-b]pyridin-6(7H)-ones and their N1-alkyl derivatives as new scaffolds for designing non-benzodiazepine BZ receptor ligands.

MeSH terms

  • Animals
  • Benzodiazepines / chemistry
  • Benzodiazepines / pharmacology
  • Drug Design*
  • Hypnotics and Sedatives / chemical synthesis*
  • Hypnotics and Sedatives / chemistry
  • Hypnotics and Sedatives / pharmacology
  • Male
  • Pyrazoles / chemistry
  • Pyridines / chemistry
  • Pyridines / pharmacology
  • Pyridones / chemical synthesis*
  • Pyridones / chemistry
  • Pyridones / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, GABA-A / drug effects
  • Structure-Activity Relationship
  • Thiophenes / chemistry
  • Thiophenes / pharmacology
  • Zolpidem

Substances

  • Hypnotics and Sedatives
  • Pyrazoles
  • Pyridines
  • Pyridones
  • Receptors, GABA-A
  • Thiophenes
  • Benzodiazepines
  • Zolpidem
  • indiplon